The maps the involvement of these mutated genes in critical signaling pathways, such as the TP53 and PI3K pathways, where nodes are color-coded to indicate the mutation frequency, further linking the pathway alterations to the aggressive tumor behavior observed in high-MLTS patients. This evidence concerns the gene TP53 and neoplasm.